Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
5
Neutral
4
Bullish
5
Bearish
35
Neutral
4
Bullish
7
Bearish
30
Neutral
0
Bullish
2
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Nephro Care India Limited is a healthcare service provider specializing in comprehensive renal care solutions based in Kolkata. They offer a one-stop treatment center catering to lifestyle, physiological, and spiritual wellness for renal patients.
Founded by Dr. Pratim Sengupta in 2014, the company transitioned from a private to a public limited company in March 2024. Utilizing a skilled team and sufficient infrastructure, Nephro Care provides non-invasive renal services.
In 2021, Nephro Care launched its flagship clinic in Salt Lake, Kolkata, and expanded with two satellite clinics in 2023. The clinics are equipped with advanced diagnostic tools to support dialysis services.
Nephro Care operates various healthcare services including in-house dialysis units, outpatient services in multiple specialties, and home care solutions. The company also has several advanced diagnostic facilities.
The high cost of dialysis poses financial challenges for families, but Nephro Care offers technologically advanced equipment to aid efficient and affordable care.
Healthcare
Hospitals / Medical Services
120 Cr
Low Risk
30.5
60.4
—
2.2
183.00
65.50
Sales CAGR
Profit CAGR
ROE
ROCE
Nephro Care India Ltd (NEPHROCARE) is currently trading at 72.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Nephro Care India Limited is a healthcare service provider specializing in comprehensive renal care solutions based in Kolkata. They offer a one-stop treatment center catering to lifestyle, physiological, and spiritual wellness for renal patients. Founded by Dr. Pratim Sengupta in 2014, the company transitioned from a private to a public limited company in March 2024. Utilizing a skilled team and sufficient infrastructure, Nephro Care provides non-invasive renal services. In 2021, Nephro Care launched its flagship clinic in Salt Lake, Kolkata, and expanded with two satellite clinics in 2023. The clinics are equipped with advanced diagnostic tools to support dialysis services. Nephro Care operates various healthcare services including in-house dialysis units, outpatient services in multiple specialties, and home care solutions. The company also has several advanced diagnostic facilities. The high cost of dialysis poses financial challenges for families, but Nephro Care offers technologically advanced equipment to aid efficient and affordable care.
Over the past 52 weeks, Nephro Care India Ltd has traded between a low of ₹65.50 and a high of ₹183.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Nephro Care India Ltd has a market capitalization of approximately 119.77. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Nephro Care India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.53 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 119.77 Cr, Nephro Care India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Nephro Care India Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Nephro Care India Ltd is 30.53. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Investor Presentation
Q4 FY25
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
74.50 | 174 Cr | 53.21 | 1.75 | 0.00 | 1.13 | 2.34 | 2.08 | |
219.05 | 148 Cr | 24.92 | 5.56 | 0.00 | 0.52 | 4.98 | 0.33 | |
72.65 | 120 Cr | 30.53 | 2.24 | 0.00 | 6.13 | 8.59 | 5.07 | |
51.90 | 97 Cr | 21.36 | 2.82 | 0.00 | 13.19 | 14.48 | 12.21 | |
60.05 | 85 Cr | 9.80 | 1.70 | 0.00 | 0.00 | 0.00 | -1.10 | |
44.45 | 61 Cr | 23.64 | 1.70 | 0.00 | 5.09 | 6.48 | 3.76 |
